Overview

Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease

Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to provide this investigational drug to patients who cannot be optimally treated with conventional therapies and to collect efficacy and safety data on the use of Metvix PDT in subjects with field actinic keratoses, large/multiple superficial basal cell carcinomas (BCCs) or Bowen's disease.
Details
Lead Sponsor:
Galderma
Galderma R&D
Treatments:
Aminolevulinic Acid
Methyl 5-aminolevulinate